Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 171546, 7 pages
http://dx.doi.org/10.1155/2014/171546
Research Article

L-Arginine Supplementation in Type II Diabetic Rats Preserves Renal Function and Improves Insulin Sensitivity by Altering the Nitric Oxide Pathway

1Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, 228 Irvine, Athens, OH 45701, USA
2The Diabetes Institute at Ohio University, Ohio University, 228 Irvine, Athens, OH 45701, USA
3Department of Specialty Medicine, Heritage College of Osteopathic Medicine, Ohio University, 228 Irvine, Athens, OH 45701, USA

Received 5 August 2013; Accepted 4 December 2013; Published 12 January 2014

Academic Editor: Stephen Fava

Copyright © 2014 Taylor Claybaugh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Remuzzi, M. Macia, and P. Ruggenenti, “Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study,” Journal of the American Society of Nephrology, vol. 17, no. 4, supplement 2, pp. S90–S97, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. T. H. Hostetter, J. L. Troy, and B. M. Brenner, “Glomerular hemodynamics in experimental diabetes mellitus,” Kidney International, vol. 19, no. 3, pp. 410–415, 1981. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Fowler, “Microvascular and macrovascular complications of diabetes,” Clinical Diabetes, vol. 26, no. 2, pp. 77–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Blouet, F. Mariotti, V. Mathe, D. Tome, and J.-F. Huneau, “Nitric oxide bioavailability and not production is first altered during the onset of insulin resistance in sucrose-fed rats,” Experimental Biology and Medicine, vol. 232, no. 11, pp. 1458–1464, 2007. View at Google Scholar · View at Scopus
  5. I. Buchwalow, J. Schnekenburger, K. Tiemann et al., “L-arginine-NO-cGMP signaling pathway in pancreatitis,” Scientific Reports, vol. 3, article 1899, 2013. View at Publisher · View at Google Scholar
  6. F. Bourgoin, H. Bachelard, M. Badeau et al., “Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 295, no. 3, pp. H1044–H1055, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Shaker, N. A. Ghallab, E. Hamdy, and S. Sayed, “Inducible nitric oxide synthase (iNOS) in gingival tissues of chronic periodontitis with and without diabetes: immunohistochemistry and RT-PCR study,” Archives of Oral Biology, vol. 58, no. 10, pp. 1397–1406, 2013. View at Publisher · View at Google Scholar
  8. M. P. Schiaich, D. Schmitt, C. Ott, B. M. Schmidt, and R. E. Schmieder, “Basal nitric oxide synthaseactivity is a major determinant of glomerular hemodynamics in humans,” Journal of hypertension, vol. 26, no. 1, pp. 110–116, 2008. View at Google Scholar
  9. J. Lorin, M. Zeller, J.-C. Guilland, Y. Cottin, C. Vergely, and L. Rochette, “Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects,” Molecular Nutrition & Food Research, 2013. View at Publisher · View at Google Scholar
  10. Y. C. Luiking, G. A. T. Have, R. R. Wolfe, and N. E. Deutz, “Arginine de novo and nitric oxide production in disease states,” American Journal of Physiology: Endocrinology and Metabolism, vol. 303, no. 10, pp. E1177–E1189, 2012. View at Publisher · View at Google Scholar
  11. A. Jabłecka, P. Bogdański, N. Balcer, A. Cieślewicz, A. Skołuda, and K. Musialik, “The effect of oral L-arginine supplementation on fasting glucose, HbA1c, nitric oxide and total antioxidant status in diabetic patients with atherosclerotic peripheral arterial disease of lower extremities,” European Review for Medical and Pharmacological Sciences, vol. 16, no. 3, pp. 342–350, 2012. View at Google Scholar · View at Scopus
  12. Y. Slyvka, S. R. Inman, R. Malgor et al., “Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese zucker rat,” Endocrine, vol. 35, no. 1, pp. 89–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Dutta, D. A. Podolin, M. B. Davidson, and A. J. Davidoff, “Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance,” Diabetes, vol. 50, no. 5, pp. 1186–1192, 2001. View at Google Scholar · View at Scopus
  14. B. Betz, K. Möller-Ehrlich, T. Kress et al., “Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency,” Translational Research, vol. 162, no. 2, pp. 67–76, 2013. View at Publisher · View at Google Scholar
  15. S. Aiello, G. Remuzzi, and M. Noris, “Nitric oxide/endothelin balance after nephron reduction,” Kidney International Supplements, vol. 65, pp. S63–S67, 1998. View at Google Scholar · View at Scopus
  16. H. Toba, N. Sawai, M. Morishita et al., “Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat,” European Journal of Pharmacology, vol. 612, no. 1–3, pp. 106–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Tunctan, B. Korkmaz, A. N. Sari et al., “Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91phox to the protective effect of 5, 14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock,” Nitric Oxide, vol. 33, pp. 18–41, 2013. View at Publisher · View at Google Scholar
  18. S. M. Morris Jr., T. Gao, T. K. Cooper, D. Kepka-Lenhart, and A. S. Awad, “Arginase-2 mediates diabetic renal injury,” Diabetes, vol. 60, no. 11, pp. 3015–3022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Bellinghieri, D. Santoro, A. Mallamace, and V. Savica, “L-arginine: a new opportunity in the management of clinical derangements in dialysis patients,” Journal of Renal Nutrition, vol. 16, no. 3, pp. 245–247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. R. di Paola, D. Impellizzeri, P. Mondello et al., “Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice,” Shock, vol. 38, no. 4, pp. 356–366, 2012. View at Google Scholar
  21. M. Peeri, M. Habibian, M. A. Azarbayjani, and M. Hedayati, “Protective effect of aerobic exercise against L-name-induced kidney damage in rats,” Archives of Industrial Hygiene and Toxicology, vol. 64, no. 2, pp. 43–49, 2013. View at Google Scholar
  22. E. M. Awumey, L. E. Bridges, C. L. Williams, and D. I. Diz, “Nitric-oxide synthase knockout modulates Ca2+-sensing receptor expression and signaling in mouse mesenteric arteries,” The Journal of Pharmacology and Experimental Therapeutics, vol. 346, no. 1, pp. 38–47, 2013. View at Publisher · View at Google Scholar